Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

eastman chemical co. - EMN

EMN

Close Chg Chg %
63.87 -1.52 -2.38%

Pre-Market

62.35

-1.52 (2.38%)

Volume: 1.76M

Last Updated:

Oct 16, 2026, 3:59 PM EDT

Trade Now

Company Overview: eastman chemical co. - EMN

EMN Key Data

Open

$63.24

 Day Range

62.09 - 64.26

52 Week Range

56.12 - 83.36

 Market Cap

$7.19B

Shares Outstanding

114.38M

 Public Float

113.31M

Beta

1.08

 Rev. Per Employee

N/A

P/E Ratio

16.38

 EPS

$3.87

Yield

534.35%

 Dividend

$0.84

EX-DIVIDEND DATE

Sep 15, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.40M

  

EMN Performance

1 Week
 
 -0.57%
 
1 Month
 
 -5.11%
 
3 Months
 
 -9.14%
 
1 Year
 
 1.71%
 
5 Years
 
 -42.06%
 

EMN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 21
Full Ratings ➔

About eastman chemical co. - EMN

Eastman Chemical Co. engages in the provision of specialty chemicals. It operates through the following segments: Advanced Material (AM), Additives and Functional Products (AFP), Chemical Intermediates (CI), and Fibers. The AM segment produces and markets its polymers, films, and plastics with differentiated performance properties for value-added end uses in transportation, consumables, building and construction, durable goods, and health and wellness markets. The AFP segment includes chemicals for products in the transportation, consumables, building and construction, animal nutrition, crop protection, energy, personal and home care, and other markets. The CI segment refers to large scale and vertical integration from the cellulose and acetyl, olefins, and alkylamines streams to support operating segments with advantaged cost positions. The Fibers segment offers cellulose acetate tow for use in filtration media, primarily cigarette filters. The company was founded by George Eastman in 1920 and is headquartered in Kingsport, TN.

EMN At a Glance

Eastman Chemical Co.
200 South Wilcox Drive
Kingsport, Tennessee 37662
Phone 1-423-229-2000 Revenue 8.76B
Industry Chemicals: Specialty Net Income 474.00M
Sector Process Industries Employees 13,000
Fiscal Year-end 12 / 2026
View SEC Filings

EMN Valuation

P/E Current 16.381
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 15.567
Price to Sales Ratio 0.842
Price to Book Ratio 1.221
Price to Cash Flow Ratio 7.61
Enterprise Value to EBITDA 8.104
Enterprise Value to Sales 1.352
Total Debt to Enterprise Value 0.419

EMN Efficiency

Revenue/Employee 674,076.923
Income Per Employee 36,461.538
Receivables Turnover 8.772
Total Asset Turnover 0.583

EMN Liquidity

Current Ratio 1.374
Quick Ratio 0.628
Cash Ratio 0.213

EMN Profitability

Gross Margin 21.248
Operating Margin 10.83
Pretax Margin 6.482
Net Margin 5.409
Return on Assets 3.152
Return on Equity 8.075
Return on Total Capital 4.34
Return on Invested Capital 4.575

EMN Capital Structure

Total Debt to Total Equity 83.208
Total Debt to Total Capital 45.417
Total Debt to Total Assets 33.38
Long-Term Debt to Equity 72.438
Long-Term Debt to Total Capital 39.539
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Eastman Chemical Co. - EMN

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
10.54B 9.20B 9.37B 8.76B
Sales Growth
+0.50% -12.69% +1.91% -6.52%
Cost of Goods Sold (COGS) incl D&A
8.48B 7.14B 7.04B 6.90B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
477.00M 498.00M 509.00M 513.00M
Depreciation
390.00M 412.00M 427.00M 434.00M
Amortization of Intangibles
87.00M 86.00M 82.00M 79.00M
COGS Growth
+6.45% -15.84% -1.29% -2.03%
Gross Income
2.06B 2.06B 2.33B 1.86B
Gross Income Growth
-18.35% +0.29% +13.00% -20.09%
Gross Profit Margin
+19.52% +22.42% +24.86% +21.25%
2022 2023 2024 2025 5-year trend
SG&A Expense
972.00M 966.00M 986.00M 913.00M
Research & Development
264.00M 239.00M 250.00M 255.00M
Other SG&A
708.00M 727.00M 736.00M 658.00M
SGA Growth
-7.34% -0.62% +2.07% -7.40%
Other Operating Expense
- - - -
-
Unusual Expense
81.00M 65.00M 73.00M 85.00M
EBIT after Unusual Expense
1.00B 1.03B 1.27B 864.00M
Non Operating Income/Expense
156.00M 278.00M 20.00M (77.00M)
Non-Operating Interest Income
6.00M 10.00M 16.00M 11.00M
Equity in Earnings of Affiliates
- 19.00M 10.00M 1.00M
Interest Expense
182.00M 222.00M 213.00M 219.00M
Interest Expense Growth
-5.21% +21.98% -4.05% +2.82%
Gross Interest Expense
191.00M 240.00M 230.00M 234.00M
Interest Capitalized
9.00M 18.00M 17.00M 15.00M
Pretax Income
977.00M 1.09B 1.08B 568.00M
Pretax Income Growth
-9.70% +11.26% -0.83% -47.31%
Pretax Margin
+9.27% +11.82% +11.50% +6.48%
Income Tax
181.00M 191.00M 170.00M 93.00M
Income Tax - Current - Domestic
212.00M 140.00M 46.00M (161.00M)
Income Tax - Current - Foreign
105.00M 153.00M 176.00M 113.00M
Income Tax - Deferred - Domestic
(126.00M) (67.00M) (93.00M) 133.00M
Income Tax - Deferred - Foreign
(10.00M) (35.00M) 41.00M 8.00M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- 19.00M 10.00M 1.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
796.00M 896.00M 908.00M 475.00M
Minority Interest Expense
3.00M 2.00M 3.00M 1.00M
Net Income
793.00M 894.00M 905.00M 474.00M
Net Income Growth
-7.47% +12.74% +1.23% -47.62%
Net Margin Growth
+7.53% +9.72% +9.65% +5.41%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
793.00M 894.00M 905.00M 474.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
793.00M 894.00M 905.00M 474.00M
EPS (Basic)
6.421 7.5379 7.7549 4.1325
EPS (Basic) Growth
+1.07% +17.39% +2.88% -46.71%
Basic Shares Outstanding
123.50M 118.60M 116.70M 114.70M
EPS (Diluted)
6.3491 7.4874 7.676 4.1004
EPS (Diluted) Growth
+1.57% +17.93% +2.52% -46.58%
Diluted Shares Outstanding
124.90M 119.40M 117.90M 115.60M
EBITDA
1.56B 1.59B 1.85B 1.46B
EBITDA Growth
-22.22% +2.11% +16.25% -21.10%
EBITDA Margin
+14.82% +17.33% +19.77% +16.68%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 75.875
Number of Ratings 21 Current Quarters Estimate 1.342
FY Report Date 12 / 2026 Current Year's Estimate 6.33
Last Quarter’s Earnings 1.941 Median PE on CY Estimate N/A
Year Ago Earnings 5.42 Next Fiscal Year Estimate 6.682
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 17 5 17 16
Mean Estimate 1.34 1.43 6.33 6.68
High Estimates 1.65 1.57 6.70 7.04
Low Estimate 0.98 1.31 6.00 6.25
Coefficient of Variance 10.79 6.55 2.45 3.71

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 8
OVERWEIGHT 1 1 1
HOLD 12 10 9
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Eastman Chemical Co. - EMN

Date Name Shares Transaction Value
Oct 12, 2026 Brett D. Begemann Director 61,396 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Eric L. Butler Director 3,798 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Linnie M. Haynesworth Director 6,405 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Kim Ann Mink Director 18,409 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Humberto P. Alfonso Director 60,995 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Humberto P. Alfonso Director 58,750 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Damon J. Audia Director 6,042 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Damon J. Audia Director 5,276 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Julie Fasone Holder Director 15,948 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Renée J. Hornbaker Director 53,088 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Donald W. Slager Director 2,227 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 Brett D. Begemann Director 63,709 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 12, 2026 James J. O'Brien Director 19,159 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2026 Adrian J. Holt SVP, Chf HR Ofcr 32,116 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2026 Adrian J. Holt SVP, Chf HR Ofcr 4,419 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2026 Mark J. Costa CEO & Board Chair; Director 31,993 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2026 Mark J. Costa CEO & Board Chair; Director 232,559 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2026 Julie A. McAlindon SVP, Regions & Chf SupChn Ofcr 24,364 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2026 Julie A. McAlindon SVP, Regions & Chf SupChn Ofcr 3,352 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2026 Brad A. Lich EVP & CCO 63,123 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Eastman Chemical Co. in the News